• LAST PRICE
    3.0350
  • TODAY'S CHANGE (%)
    Trending Up0.0950 (3.2313%)
  • Bid / Lots
    3.0200/ 1
  • Ask / Lots
    3.0400/ 4
  • Open / Previous Close
    2.9700 / 2.9400
  • Day Range
    Low 2.9450
    High 3.0755
  • 52 Week Range
    Low 2.7500
    High 8.4000
  • Volume
    39,367
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.94
TimeVolumeCAPR
09:32 ET24042.945
09:35 ET1002.97
09:53 ET12802.98
09:55 ET1002.985
10:00 ET2303.004
10:02 ET83933
10:04 ET12503.0755
10:06 ET10003
10:15 ET4762.9489
10:18 ET7062.99
10:31 ET10003
10:33 ET9673.01
10:36 ET22983.05
10:44 ET9003.045
10:54 ET1303.05
11:02 ET1003.05
11:12 ET8003.05
11:14 ET22403.04
11:16 ET6003.02
11:27 ET20003.03
11:36 ET1002.995
11:39 ET3552.9749
11:43 ET1002.995
11:45 ET25242.98
12:01 ET3003.005
12:06 ET1423.005
12:28 ET1003.02
12:33 ET1003.005
12:37 ET1003.0176
12:48 ET2653.005
12:50 ET3443.01
12:51 ET1003
12:55 ET3002.995
01:02 ET2002.995
01:06 ET4002.995
01:15 ET6003.005
01:18 ET1003.005
01:22 ET1003.01
01:26 ET1003.02
01:29 ET1003.01
01:36 ET3003.01
01:45 ET2003.005
01:47 ET2003.01
01:51 ET4003.02
01:58 ET1003.05
02:00 ET2003.035
02:07 ET1003.02
02:12 ET1003.035
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCAPR
Capricor Therapeutics Inc
71.0M
-3.7x
---
United StatesAGTC
Applied Genetic Technologies Corp
71.6M
-1.0x
---
United StatesAXLA
Axcella Health Inc
71.2M
-1.1x
---
United StatesRZLT
Rezolute Inc
71.5M
-1.5x
---
United StatesMRKR
Marker Therapeutics Inc
69.8M
-1.3x
---
United StatesLTRN
Lantern Pharma Inc.
71.5M
-5.2x
---
As of 2022-01-20

Company Information

Capricor Therapeutics, Inc. is a biotechnology company. The Company is focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of diseases. It consists of cell therapy program, including CAP-1002 with Duchenne muscular dystrophy program and CAP-1002 with COVID-19 (SARS-CoV-2) program. It also includes exosomes program, such as exosome-based vaccines, exosome-based therapeutics and CDC-Derived Exosomes (CAP-2003). Duchenne muscular dystrophy program has completed HOPE-2, a Phase II clinical trial in the United States with its product candidate.CAP-1002 is a cardiac cell derived therapy used to treat patients with late-stage Duchenne muscular dystrophy. The Company has received the United States Food and Drug Administration (FDA) acceptance of its investigational new drug (IND) application for a clinical study of CAP-1002 in patients with severe or critical COVID-19.

Contact Information

Headquarters
8840 Wilshire Blvd Fl 2BEVERLY HILLS, CA, United States 90211-2606
Phone
310-358-3200
Fax
302-655-5049

Executives

Executive Chairman of the Board
Frank Litvack
President, Chief Executive Officer, Director
Linda Marban
Chief Financial Officer, Principal Accounting Officer
Anthony Bergmann
Executive Vice President, General Counsel
Karen Krasney
Director
Karimah Es Sabar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$71.0M
Revenue (TTM)
$302.7K
Shares Outstanding
24.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
6.00
EPS
$-0.81
Book Value
$1.37
P/E Ratio
-3.7x
Price/Sales (TTM)
234.5
Price/Cash Flow (TTM)
---
Operating Margin
-6,085.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.